Selected Publications
Paul G Rubinstein, MD, Page C Moore, PhD, Milan Bimali, PhD, Jeanette Y Lee, PhD, Michelle A Rudek, PhD, Amy Chadburn, MD, Lee Ratner, MD, David H Henry, MD, Ethel Cesarman, MD, Camille E DeMarco, MPH, Dominique Costagliola, PhD, Yassine Taoufik, PhD, Juan Carlos Ramos, MD, Elad Sharon, MD, Erin G Reid, MD, Richard F Ambinder, MD, Ronald Mitsuyasu, MD, Nicolas Mounier, MD, Caroline Besson, MD, Ariela Noy, MD for the AIDS Malignancy Consortium and the Lymphoma Study Association †: Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial The Lancet 10 (8): E624-E632,2023.
David Henry: A commentary on: Circulating Tumor DNA Following Neoadjuvant Chemotherapy and Surgery in ER-Positive and HER2-Negative Breast Cancer Practice Update : 2023.
David Henry: A Commentary On: Adjuvant Osimertinib for Resected EFGR-Mutated Stage Ib-IIIA NSCLC Practice Update : 2023.
David Henry: A commentary on: Nivolumab Plus Brentuximab Vedotin for Low-Risk Relapsed Classic Hodgkin Lymphoma Practice Update : 2023.
David Henry: A Commentary On: Neoadjuvant Chemoradiation for Treatment of LARC Practice Update : 2023.
John A. Glaspy, Nashat Y Gabrail, Patricia A. Locantore-Ford, Gopal C Saha, Elise Hardy, Tyson Lee, Katharina Modelska, David H. Henry: Open‐label, Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non‐myeloid malignancies Journal of Clinical Oncology : 2023.
David Henry: 2022 Top Story in Oncology: Durvalumab Plus Gemcitabine and Cisplatin as First-Line Treatment for Advanced Biliary Tract Cancer Practice update : 2022.
Hajizadeh Barfejani, A; Prasad, S; Henry, D.: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA HemaSphere 6 : 2093-2194,2022.
David Henry: A commentary on: ASCO 2022: Abstract Recommendations Practice Update : 2022.
Prasad Siobhan, Barfejani Arnavaz, Henry David, FEVER STATUS AND: ANTIBIOTIC DELIVERY IN THE NEUTROPENIC PATIENT Supportive Care in Cancer MASCC/ISOO Annual Meeting : S1–S207,2022.
Academic Contact Information
Penn Hematology/Oncology
Abramson Cancer Center
Pennsylvania Hospital, Farm Journal Building
230 West Washington Square
Philadelphia,
PA
19106
Phone: 215-829-6088
Patient appointments: 800-789-7366